Vynca Appoints Veteran Palliative Care Leader Jill Schwartz-Chevlin, MD, MBA, FACP, as Chief Medical Officer

Palliative Care Leader Brings Deep Expertise to Advance Value-Based Serious Illness Care

SAN FRANCISCO–(BUSINESS WIRE)–Vynca, a health technology and services company supporting individuals with serious illness and complex needs, today announced the appointment of Jill Schwartz-Chevlin, MD, MBA, FACP, as Chief Medical Officer. In this role, Dr. Schwartz-Chevlin will lead Vynca’s clinical strategy, guiding the integration of tech-enabled palliative care, predictive analytics, and scalable care models to improve patient outcomes while reducing avoidable care utilization for health plans.

Dr. Schwartz-Chevlin brings over two decades of experience building and leading home-based, value-based care models for medically complex populations. Most recently, she served as Chief Medical Officer for Serious Illness at WellBe Senior Medical, where she directed population-level palliative care strategy for more than 50,000 patients across nine states, driving a 40% reduction in hospital utilization and implementing accountability-based referral models that exceeded 85% hospice conversion benchmarks.

Previously, Dr. Schwartz-Chevlin served as Senior Medical Officer, National Palliative Care Lead at Landmark Health (now Optum Health). Here, she developed and scaled national palliative care programs across 20+ states, covering more than 60,000 lives and achieving a 26% reduction in medical costs for the highest-risk populations. Earlier in her career, she founded and led a profitable home-based primary and palliative care practice and served as the founding Medical Director of Greenwood Hospice, providing direct care to thousands of patients for more than a decade.

“Access to high-quality palliative care in the community across the country for patients not in hospice care is very limited, despite its proven, positive impact on quality of life and the cost of care,” says Darren Schulte, MD, MPP, CEO of Vynca. “At Vynca, we address the clinical, social, and behavioral issues related to living with serious illness using in-home and telehealth visits. We improve our patients’ symptoms and document their goals of care. Our technology allows us to identify patients with unmet needs, provide accessible care options, and anticipate and avoid crises. Jill’s rare depth across clinical leadership, payer collaboration, and operational execution will strengthen Vynca’s ability to deliver earlier, more effective interventions that benefit patients, providers, and health plans alike.”

Since 2013, Vynca has partnered with health plans and health systems nationwide to support people living with serious illnesses through tech-enabled palliative care and navigation. Vynca’s unique model has demonstrated a 43% reduction in emergency department visits and a 52% reduction in hospital admissions, generating $1,700 to $3,400 in average monthly savings per patient while improving quality of life.

“As the population ages and serious illness becomes more prevalent, and with healthcare policy in critical flux, it’s more important than ever that stakeholders are aware of palliative care options,” says Dr. Schwartz-Chevlin. “Vynca’s approach—combining predictive insights with interdisciplinary, patient-centered care—creates an opportunity to reach people earlier, align care with what matters most to them, and reduce unnecessary suffering and utilization. I’m excited to advance that mission alongside health plans and care partners nationwide.”

Dr. Schwartz-Chevlin’s appointment reflects Vynca’s continued investment in clinical leadership as the company expands partnerships with health plans and providers seeking scalable, value-based solutions for serious illness care.

About Vynca

Vynca is a health technology and services company transforming how care is delivered to people living with serious illness—bringing high-touch, tech-enabled palliative care and navigation into the home and community. Our hybrid model combines in-person and virtual support with predictive technology to orchestrate care, intervene early, reduce avoidable hospitalizations, and improve quality of life.

Contacts

SolComms
Hannah Melillo
[e-mail]